PhRMA, Others Look For Savings In Reduced Drug Interactions
Executive Summary
Reducing the instances of adverse events related to drug-drug interactions is among the options to reduce health care spending presented by both the Pharmaceutical Research and Manufacturers of America and the American Medical Association